Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)

Clinical trial NCT00268671 · COMPLETED

Trial details

NCT number: NCT00268671
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2003-08-01
Primary completion: 2006-04-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.